The pathophysiology of cachexia in chronic obstructive pulmonary disease
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: The focus of this review is on translation of putative mechanisms of altered energy metabolism and muscle maintenance in cachexia to clinical comparative and intervention studies on chronic obstructive pulmonary disease (COPD). RECENT FINDINGS: Pulmonary cachexia is a well recognized feature of COPD, but its cause is poorly understood. Recent studies have shed new light on the molecular mechanisms that underlie cachexia in this disorder. In addition to muscle wasting, COPD patients also suffer from so-called loss of peripheral 'muscle oxidative phenotype', rendering these muscles less energy efficient and more prone to oxidative stress, which may in turn augment loss of muscle mass. SUMMARY: Recent translational approaches have clearly advanced our understanding of the pathophysiology of cachexia in COPD. Although this complex clinical syndrome may clearly benefit from multidimensional interventions, for a tailored therapeutic approach based on distinct wasting and pulmonary phenotypes, more mechanistic knowledge on abnormal regulation of energy balance and muscle maintenance in COPD cachexia is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Effects of Omega-3 Polyunsaturated Fatty Acids on Inflammatory Markers in COPD
Matsuyama, W., Mitsuyama, H., Watanabe, M., Oonakahara, K.-I., Higashimoto, I., Osame, M., & Arimura, K. (2005) · Chest · doi:10.1378/chest.128.6.3817 · Cited by 108
RetractedSkeletal muscle hypertrophy and atrophy signaling pathways
Glass, D. J. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.04.018 · Cited by 1,106
Body composition and mortality in chronic obstructive pulmonary disease
Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.1.53 · Cited by 902
Self-citationSkeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary Disease
Agustí, A. G. N., Sauleda, J., Miralles, C., Gomez, C., Togores, B., Sala, E., Batle, S., & Busquets, X. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108013 · Cited by 343
TNF- downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents
Valerio, A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28570 · Cited by 327
Muscle Atrophy and Hypertrophy Signaling in Patients with Chronic Obstructive Pulmonary Disease
Doucet, M., Russell, A. P., Léger, B., Debigaré, R., Joanisse, D. R., Caron, M.-A., LeBlanc, P., & Maltais, F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-704oc · Cited by 243
Gosker, H. R., Engelen, M. P., van Mameren, H., van Dijk, P. J., van der Vusse, G. J., Wouters, E. F., & Schols, A. M. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/76.1.113 · Cited by 200
Self-citationAbnormal Mitochondrial Function in Locomotor and Respiratory Muscles of COPD Patients
Puente-Maestu, L., Pérez-Parra, J., Godoy, R., Moreno, N., Tejedor, A., González-Aragoneses, F., Bravo, J.-L., Villar Álvarez, F., Camaño, S., & Agustí, A. (2009) · European Respiratory Journal · doi:10.1183/09031936.00112408 · Cited by 172
Peroxisome Proliferator-Activated Receptor Expression Is Reduced in Skeletal Muscle in COPD
Remels, A. H., Schrauwen, P., Broekhuizen, R., Willems, J., Kersten, S., Gosker, H. R., & Schols, A. M. (2007) · European Respiratory Journal · doi:10.1183/09031936.00144106 · Cited by 168
Self-citationMitochondrial Dysfunction in COPD Patients with Low Body Mass Index
Rabinovich, R. A., Bastos, R., Ardite, E., Llinàs, L., Orozco-Levi, M., Gea, J., Vilaró, J., Barberà, J. A., Rodríguez-Roisin, R., Fernández-Checa, J. C., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00086306 · Cited by 144
Cited by
Beneficial bacteria inhibit cachexia
Varian, B. J., Goureshetti, S., Poutahidis, T., Lakritz, J. R., Levkovich, T., Kwok, C., Teliousis, K., Ibrahim, Y. M., Mirabal, S., & Erdman, S. E. (2016) · Oncotarget · doi:10.18632/oncotarget.7730 · Cited by 146
Immunologic Impact of Nutrient Depletion in Chronic Obstructive Pulmonary Disease
Herzog, R., & Cunningham-Rundles, S. (2011) · Current Drug Targets · doi:10.2174/138945011794751500 · Cited by 23
“Fat wasting appears to be more prevalent in advanced disease and in the emphysematous subtype [37].”
BackgroundKochetkova, E. A., Nevzorova, V. A., Ugai, L. G., Maistrovskaia, Y. V., & Massard, G. (2016) · Calcified Tissue International · doi:10.1007/s00223-016-0185-8 · Cited by 9
Metadata
- Authors
- Schols, A. M., & Gosker, H. R.
- Venue
- Current Opinion in Supportive & Palliative Care
- Published
- 2009-12
- Volume
- 3
- Issue
- 4
- Pages
- 282-287
- ISSN
- 1751-4258 (ISSN-L)
- OpenAlex
- W2090728490
- Cited by
- 40
- References
- 15
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The pathophysiology of cachexia in chronic obstructive pulmonary disease. https://app.cochat.ai/papers/10.1097/spc.0b013e328331e91c
- The paper
- Schols, A. M., & Gosker, H. R. (2009). The pathophysiology of cachexia in chronic obstructive pulmonary disease. Current Opinion in Supportive & Palliative Care. https://doi.org/10.1097/spc.0b013e328331e91c
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.